Compare · OACC vs PRE
OACC vs PRE
Side-by-side comparison of Oaktree Acquisition Corp. III Life Sciences (OACC) and Prenetics Global Limited (PRE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OACC and PRE operate in Blank Checks (Finance), so they compete in similar markets.
- PRE carries a market cap of $276.6M.
- PRE has been more active in the news (11 items in the past 4 weeks vs 3 for OACC).
- PRE has more recent analyst coverage (8 ratings vs 0 for OACC).
Latest OACC
- Amendment: SEC Form SCHEDULE 13G/A filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form 10-Q filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form 8-K filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form 4 filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form DEFA14A filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form 8-K filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form DEFA14A filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form 8-K filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form DEF 14A filed by Oaktree Acquisition Corp. III Life Sciences
- SEC Form PRE 14A filed by Oaktree Acquisition Corp. III Life Sciences
Latest PRE
- SEC Form 6-K filed by Prenetics Global Limited
- Prenetics’ IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230 Million and FY 2027 IM8 Revenue Guidance of $400 Million+
- SEC Form 6-K filed by Prenetics Global Limited
- Prenetics’ IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
- Director Leogrande Hudson Blake converted options into 2,000 units of Class A Ordinary Share, increasing direct ownership by 25% to 10,001 units (SEC Form 4)
- SEC Form 6-K filed by Prenetics Global Limited
- Care Bears And Prenetics' IM8 Announce Global Partnership
- SEC Form 6-K filed by Prenetics Global Limited
- Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
- SEC Form 6-K filed by Prenetics Global Limited